Clinical trial
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
NCT02186119 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- June 30, 2015
- Enrollment
- 151 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.